Home > Insider Trading > Filing (0001209191-13-042095)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100962	Endo Health Solutions Inc.	ENDP	Pharmaceutical Preparations (2834)	134022871

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1179357	B Caroline Manogue	C/O Endo Health Solutions Inc. 1400 Atwater Drive Malvern PA 19355	Exec. V.p., Clo & Secy	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value, $.01 Per Share	Acquisiton	2013-08-26	130,000	$28.61	192,014	No	4	M	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2013-08-26	130,000	$39.40	62,014	No	4	S	Direct
Common Stock, Par Value, $.01 Per Share	Disposition	2013-08-26	15,592	$39.40	46,422	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2013-08-26	130,000	$0.00	130,000	$28.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-02-14	No	4	M	Direct

Footnotes

On August 9, 2013, in connection with her personal financial planning, Ms. Manogue placed 130,000 of the shares underlying her stock options and 15,592 shares of common stock, which she had obtained upon vesting of certain restricted stock units and performance share units, into a 10b5-1 pre-set selling program (the "Manogue Pre-Set Selling Program"). The Manogue Pre-Set Selling Program's initial termination date was the earlier of August 29, 2014 or the date all shares under the program were sold. The options exercised and the shares sold above were sold pursuant to the Manogue Pre-Set Selling Program, which leaves no remaining shares (underlying options or otherwise) in the current Manogue Pre-Set Selling Program.
This represents the price at which Ms. Manogue's common shares were sold on August 26, 2013.
Ms. Manogue's stock options that were granted under the 2004 Stock Incentive Plan on February 14, 2006 were generally exercisable 25% per year on each of February 14, 2007, February 14, 2008, February 14, 2009, February 14, 2010.
These securities were granted to Ms. Manogue in 2006 in consideration of her services as the Executive Vice President, Chief Legal Officer and Secretary of Endo Health Solutions Inc.